New Marketlink

What New Marketlink does

New Marketlink Pharmaceutical Corporation (NMPC) is a Philippine pharmaceutical company founded in December 2006 as a spin-out of predecessor Marketlink International Corporation (MIC) under holding company TAO Corporation. The company is headquartered in Pasig City and operates with 251–500 employees, distributing a diversified portfolio across three segments: over-the-counter (OTC) medicines, prescription (RX) drugs, and vitamins and supplements. Its OTC line includes differentiated branded products such as Acetaffein (paracetamol-caffeine combination with faster-dissolving formulation), Lagundex (organic Lagundi-leaf cough remedy), and Inlacin (herbal diabetes management); its RX line spans contrast imaging agents (Iopamiro, Multihance), oncology and immunomodulatory products (Onco-BCG, Isoprinosine), and specialty treatments (Rowachol, Rowatinex, Vaxirab-N-1); and its vitamin/supplement line includes Ener-A, Hi-Smart, Simply-Her, SkinVita, and Vitree. The portfolio is sourced through international distribution partnerships with manufacturers including Bracco, Zydus, Kedrion, Swiss Pharma, Rowa, and others.

NMPC operates a multi-channel distribution model reaching Philippine consumers, pharmacists, physicians, hospitals, and clinics. The go-to-market combines a field medical-representative sales force covering medical and paramedical professionals, traditional pharmacy and drugstore distribution nationwide, and consumer-direct e-commerce presence on Lazada and Shopee. Marketing is supported by a multi-platform digital presence (Facebook, TikTok, YouTube) and a content-marketing blog aligned with Philippine health observance campaigns such as National Pharmacy Week and disease awareness months. The company also operates an online pharmacovigilance and product-verification portal to monitor adverse drug reactions and authenticate products.

The business model is fundamentally that of a branded pharmaceutical importer and distributor: NMPC does not own manufacturing, instead sourcing finished products from international partners and monetizing through one-time sale transactions across OTC, RX, and wellness categories. Pricing is set by downstream retail channels and is not publicly disclosed. Ownership is concentrated under TAO Corporation as the parent holding entity, with no public listing, private equity, or venture capital disclosed. Leadership is held by Francis Gomez as President & CEO.

Name

New Marketlink

Legal name

New Marketlink Pharmaceutical Corporation

Website

https://nmpc.com.ph

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

251–500 employees

Short description

New Marketlink Pharmaceutical Corporation is a Philippine pharmaceutical importer and distributor, founded in 2006 under TAO Corporation, that markets OTC medicines, prescription drugs, and vitamins nationwide through pharmacy networks, a medical-representative sales force, hospitals, and Lazada/Shopee e-commerce channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAGAMAD

Specialty Pharma & Biologics Distribution (GDP-compliant)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences

SECONDARYCRAOAHAD

Specialty Pharmacy & Biologics Distribution

Consumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale Distribution

SECONDARYCRAOAHAB

OTC Medicines & Consumer Health Products Distribution

Consumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale Distribution

SECONDARYCRADAGAC

Multivitamins & Daily Packs

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

Keywords

• Pharmaceutical products
• Over-the-counter medicines
• Prescription medicines
• Vitamins and supplements
• Pharmaceutical distribution

Headquarters

HQ city

Pasig

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

1. Over-the-Counter (OTC) Medicines: Sale of non-prescription pharmaceutical products including pain relief, cough remedies, and other common ailment treatments directly to consumers through pharmacies and retail channels.
2. Prescription (RX) Medicines: Sale of prescription pharmaceutical products distributed through healthcare providers and pharmacies. Includes products like Cathejell, Iopamiro, Multihance, Onco-BCG, Rowachol, and others.
3. Vitamins and Supplements: Sale of vitamin and supplement products including Ener-A, Hi-Smart, Simply-Her, SkinVita, and Vitree through retail pharmacies and e-commerce channels.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

NMPC is a Philippine pharmaceutical distribution company that imports, markets, and distributes a diversified portfolio of healthcare products through three segments: Over-the-Counter (OTC) medicines (e.g., Acetaffein, Lagundex, Inlacin, Heart-B, Prostalmet-Plus), Prescription (RX) medicines (e.g., Iopamiro, Multihance, Isoprinosine, Onco-BCG, Rowachol, Rowatinex), and Vitamins & Supplements (e.g., Ener-A, Hi-Smart, Simply-Her, SkinVita, Vitree). Products are sourced through international pharmaceutical partners and reach Filipino consumers via pharmacy networks, healthcare providers, and e-commerce channels.

Product overview

New Marketlink Pharmaceutical Corporation (NMPC) operates as a Philippine pharmaceutical company distributing a diversified portfolio of three product lines. The Over-the-Counter (OTC) segment includes pain relief medicines such as Acetaffein (paracetamol-caffeine combination), herbal remedies like Inlacin (for diabetes) and Lagundex (Lagundi-based cough remedy), and other OTC treatments including Heart-B, Prostalmet-Plus, Ducid-Plus, Elixiflora, Lorange, and Rowagel. The Prescription (RX) segment covers diagnostic contrast agents (Iopamiro, Multihance), cancer treatments (Onco-BCG), immunomodulators (Isoprinosine), gallstone/kidney stone medications (Rowachol, Rowatinex, Rowatanal), antibiotics (IG-Tet, IG-Vena), and other Rx products (Cathejell, Kedrialb, Vaxirab-N-1, Wilopres, Iroferose). The Vitamins & Supplements segment includes Ener-A, Hi-Smart, Simply-Her, SkinVita, and Vitree. NMPC also distributes through e-commerce platforms including Lazada and Shopee.

Differentiator

Problem solved

Functional benefit

Brands

• Acetaffein: OTC product combining caffeine and paracetamol for headache relief with faster dissolving formula.
• Lagundex
• Inlacin

Products and services

• Acetaffein OTC paracetamol-caffeine combination tablet designed to dissolve faster than conventional tablets; enhances and prolongs pain relief for headaches.
• Lagundex OTC 100% organic Lagundi leaf-based cough remedy to relieve cough with phlegm and asthmatic cough for adults and children.
• Ducid-Plus Over-the-counter medication for common ailments.
• Elixiflora Over-the-counter medication.
• Heart-B Over-the-counter medication for cardiovascular health.
• Inlacin OTC herbal medicine for diabetes that balances blood glucose levels with no known contraindications.
• Lorange Over-the-counter medication.
• Prostalmet-Plus Over-the-counter medication for prostate health.
• Rowagel Over-the-counter medication.
• Cathejell Prescription pharmaceutical product distributed through healthcare providers and pharmacies.
• IG-Tet Prescription medication (immunoglobulin).
• IG-Vena Prescription medication (immunoglobulin).
• Iopamiro Prescription contrast media agent for diagnostic imaging.
• Iroferose Prescription medication for iron supplementation therapy.
• Isoprinosine Prescription immunomodulatory agent.
• Kedrialb Prescription plasma-derived albumin product (sourced from Kedrion partnership).
• Multihance Prescription MRI contrast agent for diagnostic imaging.
• Onco-BCG Prescription medication for cancer treatment.
• Rowachol Prescription medication for gallstone management.
• Rowatanal Topical analgesic prescription product.
• Rowatinex Prescription medication for kidney stone treatment.
• Vaxirab-N-1 Prescription rabies vaccine product.
• Wilopres Prescription cardiovascular medication.
• Ener-A Vitamin and supplement product distributed through retail pharmacies and e-commerce channels.
• Hi-Smart Vitamin and supplement product distributed through retail pharmacies and e-commerce channels.
• Simply-Her Vitamin and supplement product for women's health distributed through retail pharmacies and e-commerce channels.
• SkinVita Vitamin and supplement product for skin health distributed through retail pharmacies and e-commerce channels.
• Vitree Vitamin and supplement product distributed through retail pharmacies and e-commerce channels.

Quantifiable outcome

• Established as respected leader amongst national pharmaceutical companies in Philippines
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

21 partnerships are on record, tiered core and minor.

• BraccocoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical company partnership for distribution of diagnostic and imaging pharmaceutical products in the Philippines.
• ZyduscoreChannel Partner/ Reseller/ DistributorIndian pharmaceutical company partnership for generic and branded pharmaceutical products distribution.
• KedrioncoreChannel Partner/ Reseller/ DistributorItalian biopharmaceutical company specializing in plasma-derived products and重症血液制品.
• Swiss PharmacoreChannel Partner/ Reseller/ DistributorPharmaceutical products sourced from Swiss pharmaceutical manufacturer for Philippine market.
• RowacoreChannel Partner/ Reseller/ DistributorPharmaceutical partner for urology and gallstone treatment products including Rowachol, Rowatanal, and Rowatinex.
• LCPIminorChannel Partner/ Reseller/ DistributorLocal pharmaceutical distribution partner in the Philippines.
• HizonminorChannel Partner/ Reseller/ DistributorLocal pharmaceutical distribution partner in the Philippines.
• AldritzminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• TopLCminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• SMHPminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• RotexminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• NPIminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• MontavitminorChannel Partner/ Reseller/ DistributorAustrian pharmaceutical company partner.
• LifesquareminorChannel Partner/ Reseller/ DistributorPharmaceutical partner for specialty products.
• HHCminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• HBminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• GDMminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• ElixirminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• EadriexminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• AmbicaminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.
• San MarinominorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• GlaxoSmithKline Philippines: Multinational pharma major with Philippines subsidiary distributing prescription and vaccine products through distributors like NMPC — comparable in prescription/OTC categories but operating as a manufacturer-principal rather than a local distributor.
• Merck Philippines: Multinational pharma and life sciences player distributing prescription, OTC, and consumer health brands in the Philippines through local channels — comparable channel positioning but at multinational scale.
• P&G Health Philippines: Multinational consumer health player with a Philippines presence distributing vitamins and OTC brands through pharmacy channels — comparable in OTC/vitamin mix, but as part of a much larger global portfolio rather than a domestic specialist.
• AstraZeneca Philippines: Multinational pharma subsidiary distributing specialty prescription products in the Philippines — comparable prescription/specialty distribution overlap but with global R&D pipeline and substantially larger commercial scale.
• Sanofi Philippines: Multinational pharma manufacturer with Philippines operations across prescription, vaccines, and consumer health — comparable to NMPC's RX/vaccine scope but from a global manufacturer's standpoint with broader portfolio and resources.

Direct peers

• Zuellig Pharma: Asia's largest pharma distributor with deep Philippines operations (Zurihaus) handling specialty, biologics, and consumer health distribution — directly comparable pharmaceutical distribution model and geographic anchor in Southeast Asia.
• Cathay Drug Company: Philippine specialty pharmaceutical importer and distributor with prescription and consumer health products — comparable domestic distribution model and similar scale band to NMPC.
• United Laboratories (Unilab): The largest Philippine pharmaceutical company, distributing a broad OTC, prescription, and consumer health portfolio nationally — directly comparable in product breadth, channel mix (pharmacy + hospital + modern trade), and Philippines-domestic focus, but at significantly greater scale.
• Natrapharm: Philippine pharmaceutical company producing and distributing generic OTC and prescription products nationally — comparable product breadth, prescription/OTC mix, and Philippines-domestic orientation.
• Metro Drug Inc. One of the largest Philippine pharmaceutical distribution and marketing companies with multi-category coverage and nationwide reach — a like-for-like distributor-of-international-brands peer to NMPC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@NewMarketlinkPharmaceutical
• Facebookfacebook.com/NewMarketlinkPharmCorpOfficial
• TikToktiktok.com/@newmarketlinkphc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Marketlink